Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

RECRUITING

NCT05081141

HHV8 and Solid Organ Transplantation

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

View on ClinicalTrials.gov

Summary

Solid organ transplant candidates will undergo serological screening for HHV8 at time of listing and transplantation. In the event of a recipient/donor mismatch R-/D+ or in the presence of a seropositive recipient (R+), blood levels of HHV8 DNA will be monitored together with specific IGRA for HHV8.

Official title: Screening for HHV8 Infection in Solid Organ Transplantation Donors, Candidates and Recipients

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

250

Start Date

2021-09-15

Completion Date

2025-12-31

Last Updated

2024-05-07

Healthy Volunteers

Conditions

HHV8 HHV8 Infection HHV8-Related Malignant Neoplasm Kaposi Sarcoma Lung Transplant; Complications Liver Transplant; Complications Kidney Transplant; Complications Castleman Disease

Interventions

DIAGNOSTIC_TEST

Diagnostic test for HHV8 exposure

Venipuncture for blood sampling

Locations (1)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano

Milan, Italy